David Berman, MD, PhD has been appointed as Moderna ’s chief development officer, beginning March 2. The Department of Health and Human Services announced the addition of 21 members to a federal ...

A new study shows that lipid nanoparticles restructure their membrane significantly after being absorbed into a cell and ...

A study from FAU has shown that lipid nanoparticles restructure their membrane significantly after being absorbed into a cell and ending up in an acidic environment. Vaccines and other medicines are ...

The era of CureVac as an independent, publicly traded company has drawn to a close. This significant milestone follows the completion of its acquisition by riva ...

Arbutus Biotech (ABUS) heads to a key March Moderna LNP patent trial as imdusiran HBV milestones drive value—get the latest ...

TOKYO, Feb. 2, 2026 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total investment of approximately JPY 1.39 billion (USD 8.8 million (1) ) in six R&D projects ...

During a Senate Homeland Security Committee hearing, Sen. Rick Scott questioned fire and emergency management experts about what he described as 'blunders' in the handling of the Palisades Fire. Scott ...

In a leap that blurs the line between science fiction and cellular biology, scientists have turned a mysterious structure ...

Moderna (NasdaqGS:MRNA) is shifting away from self-funding new Phase III vaccine trials in response to increased vaccine ...

Sergio Pineda, Vice President of Lending at Blue Group Capital, continues to help U.S. and Canadian businesses access ...

Leveraging its integrated "design-synthesis-quality control" system, Creative Biolabs is overcoming bottlenecks in mRNA ...

In a Phase 3 trial of more than 18,000 volunteers across three countries, an mRNA influenza vaccine from Pfizer has outperformed standard seasonal flu shots by 34.5%. It's yet another sign that this ...